IA
Iowa Senate Bill SF2033

Iowa 2023-2024 Regular Session

Iowa Senate Bill SF2033

Introduced
1/9/24  
Introduced
1/9/24  

Caption

A bill for an act relating to perfluoroalkyl and polyfluorinated substances in fire fighter personal protective equipment and providing penalties.

Impact

If enacted, SF2033 would significantly impact state laws by establishing new disclosure requirements for manufacturers and sellers of firefighter PPE. Specifically, the bill requires these entities to label products containing PFAS and maintain records of such disclosures for at least three years. Additionally, state attorneys would be empowered to enforce this requirement and pursue penalties for violations, potentially leading to a more regulated market for firefighting gear. This measure seeks to protect firefighters' health by ensuring they are informed about harmful substances in their protective equipment.

Summary

Senate File 2033, introduced by Senator Webster, focuses on the regulation of perfluoroalkyl and polyfluorinated substances (PFAS) in firefighter personal protective equipment (PPE). The bill mandates that any person or manufacturer selling firefighter PPE must provide written notice to purchasers if any intentionally added PFAS are present in the equipment. This aims to enhance transparency regarding the chemical components in protective gear used by firefighters.

Contention

Debates around SF2033 could emerge regarding the balance between safety and regulation. Supporters might argue that the bill is crucial for the health and safety of firefighters, as it seeks to eliminate the risks associated with harmful substances in their gear. However, concerns may arise from manufacturers about the potential cost implications and logistical challenges of implementing these disclosures. Furthermore, some may view this as an overreach of regulatory authority, suggesting that it could hinder the availability of certain protective equipment if manufacturers opt to avoid the additional compliance burdens.

Companion Bills

No companion bills found.

Previously Filed As

IA AB2408

Firefighter personal protective equipment: perfluoroalkyl and polyfluoroalkyl substances.

IA SF254

A bill for an act prohibiting municipalities and fire departments from purchasing fire fighter equipment that does not contain a label regarding perfluoroalkyl and polyfluoroalkyl substances.

IA H0250

An act relating to perfluoroalkyl and polyfluoroalkyl substances in firefighting personal protective equipment and station wear

IA A5223

Requires manufacturer of firefighting personal protective equipment containing perfluoroalkyl and polyfluoroalkyl substances to provide written notice to purchaser.

IA S3946

Requires producer of certain firefighting equipment containing perfluoroalkyl and polyfluoroalkyl substances to provide written notice to purchaser; prohibits sale, manufacture, and distribution of certain firefighting equipment containing intentionally added perfluoroalkyl and polyfluoroalkyl substances.

IA A5195

Requires producer of certain firefighting equipment containing perfluoroalkyl and polyfluoroalkyl substances to provide written notice to purchaser; prohibits sale, manufacture, and distribution of certain firefighting equipment containing intentionally added perfluoroalkyl and polyfluoroalkyl substances.

IA HB1541

In Commonwealth services, providing for firefighting personal protective equipment; and imposing penalties.

IA HB675

In Commonwealth services, providing for firefighting personal protective equipment; and imposing penalties.

IA SF2229

A bill for an act prohibiting political subdivisions from purchasing or acquiring certain fire fighting or fire-suppressing foam containing perfluoroalkyl and polyfluoroalkyl substances.

IA HB1352

Relative to firefighting personal protective equipment.

Similar Bills

CA AB888

Opioid prescriptions: information: nonpharmacological treatments for pain.

CA SB1448

Healing arts licensees: probation status: disclosure.

US SB331

HALT Fentanyl Act Halt All Lethal Trafficking of Fentanyl Act

NJ A5836

Requires county prosecutors to publish annual report related to plea agreements and controlled dangerous substances.

US HB467

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

CA SB1395

Southern California Fentanyl Task Force.

OK SB65

Controlled dangerous substances; authorizing destruction of certain substances by certain individuals. Effective date.

US HB171

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.